BIOVIE INC.
Close on Oct 19, 2026
- Market cap
- $10.86M
- P/E (TTM)
- –
- Dividend yield
- –
Earnings
Quarterly results announced on Form 8-K, Item 2.02
No earnings releases found
Biovie has not filed an earnings release (Form 8-K, Item 2.02) that we could match to a fiscal quarter.
Press releases
Announcements Biovie filed with the SEC
BioVie Announces Topline Results of Phase 2 SUNRISE-PD
Regulation FD disclosure · EX-99.1 to Form 8-K
BioVie Inc. Announces Pricing of $12 Million
Material agreement · Unregistered share sale · Regulation FD disclosure · EX-99.1 to Form 8-K
BioVie Inc. Announces Closing of $12 Million
Material agreement · Unregistered share sale · Regulation FD disclosure · EX-99.2 to Form 8-K
BioVie Appoints Industry Veterans Amy Chappell,
Executive or director change · Regulation FD disclosure · EX-99.1 to Form 8-K
Inc. Announces Closing of Registered Direct Offering
Regulation FD disclosure · Other events · EX-99.1 to Form 8-K
Pricing of Registered Direct Offering
Material agreement · Unregistered share sale · Regulation FD disclosure · EX-99.1 to Form 8-K
Announces Closing of Registered Direct Offering and Concurrent Private Placement
Regulation FD disclosure · Other events · EX-99.1 to Form 8-K
BioVie Inc. Announces Pricing of Registered Direct
Material agreement · Unregistered share sale · Regulation FD disclosure · EX-99.1 to Form 8-K
Announces Closing of Registered Direct Offering and Concurrent Private Placement
Regulation FD disclosure · Other events · EX-99.1 to Form 8-K
Pricing of Registered Direct Offering and Concurrent Private Placement Priced At-the-Market Under Nasdaq Rules
Material agreement · Unregistered share sale · Regulation FD disclosure · EX-99.1 to Form 8-K
Announces Closing of Public Offering
Regulation FD disclosure · Other events · EX-99.1 to Form 8-K
BioVie Inc. Announces Proposed Public Offering
Material agreement · Regulation FD disclosure · EX-99.1 to Form 8-K
BioVie Inc. Announces Pricing of Public Offering
Material agreement · Regulation FD disclosure · EX-99.2 to Form 8-K
BioVie Announces Pipeline Update and Near-Term
Other events · EX-99.1 to Form 8-K
Inc. Announces Closing of Public Offering
Regulation FD disclosure · Other events · EX-99.1 to Form 8-K
EX-99.2 to Form 8-K
Regulation FD disclosure · Other events · EX-99.2 to Form 8-K
Proposed Public Offering of Common Stock
Material agreement · Regulation FD disclosure · EX-99.1 to Form 8-K
BioVie Inc. Announces Pricing of Public Offering
Material agreement · Regulation FD disclosure · EX-99.2 to Form 8-K
Improvements in Motor and Non-motor Symptoms for Parkinson’s Disease Patients and May Be Realigning Physiological Processes for
Other events · EX-99.1 to Form 8-K
BioVie Announces EfficacyData from Phase 3 Trial
Other events · EX-99.1 to Form 8-K
EX-99.2 to Form 8-K
Other events · EX-99.2 to Form 8-K
FOR RELEASE OCTOBER 25, 2023 AT 12:20PM ET
Other events · EX-99.1 to Form 8-K
EX-99.1 to Form 8-K
Regulation FD disclosure · EX-99.1 to Form 8-K
EX-99.1 to Form 8-K
Regulation FD disclosure · EX-99.1 to Form 8-K
EX-99.1 to Form 8-K
Regulation FD disclosure · EX-99.1 to Form 8-K
BioVie Issues Letter to Shareholders
Regulation FD disclosure · EX-99.2 to Form 8-K
Announces Positive Results for NE3107 in Parkinson’s and Alzheimer’s
Regulation FD disclosure · Other events · EX-99.1 to Form 8-K
from Phase 2 Alzheimer’s Disease Trial:
Regulation FD disclosure · Other events · EX-99.2 to Form 8-K
preliminary data from investigator-sponsored Phase 2 Alzheimer’s trial show high proportion
Other events · EX-99.1 to Form 8-K
BioVie and Dr. Sheldon Jordan Jointly Announce
Regulation FD disclosure · Other events · EX-99.1 to Form 8-K/A
EX-99.2 to Form 8-K/A
Regulation FD disclosure · Other events · EX-99.2 to Form 8-K/A
BioVie and Dr. Sheldon Jordan Jointly Announce
Regulation FD disclosure · Other events · EX-99.1 to Form 8-K
EX-99.2 to Form 8-K
Regulation FD disclosure · Other events · EX-99.2 to Form 8-K
Developing Transformative Therapies to Overcome Chronic Debilitating Diseases Corporate Presentation • June 2022
New financial obligation · Regulation FD disclosure · EX-99 to Form 8-K
BioVie Secures Up to a $25.0 Million Debt
Material agreement · New financial obligation · Unregistered share sale · Regulation FD disclosure · EX-99.1 to Form 8-K